Anxiety, Breast Cancer, Cancer, Cognitive Dysfunction
Conditions
Brief summary
As cancer mortality rates improve in Asia, there is an increasing focus on patient-reported outcomes and survivorship issues. In view of the numerous medication and psychosocial issues that are commonly faced by early-stage breast cancer survivors, it deems important to develop and conduct specific interventional programs to mitigate these problems. In the literature, it is well recognized that psychosocial interventions are effective to manage emotional distress and quality of life, with the evidence clearly clustered in studies on female patients with breast cancer. One meta-analysis suggested that psycho-oncologic interventions including individual psychotherapy, group psychotherapy, psychoeducation, relaxing training can produce positive effects on emotional distress, anxiety and depression, and health-related QOL. The investigators hypothesize that a significant reduction in anxiety, improvement of cognition and improvement of health-related quality of life among those who receive psycho-education, in comparison to those in the usual care. Hence, this randomized trial is designed to assess the effectiveness of a psycho-educational group (PEG) intervention on supportive care and survivorship issues, which include anxiety, depression, cognitive function, toxicities management of cancer- or treatment- related physical symptoms, and health-related quality of life in early-stage breast cancer patients.
Interventions
BEHAVIORALPsychoeducation group
On the basis of previous studies that evaluated PEG interventions for women with breast cancer, a structured program based on the Cognitive Behavioral Therapy (CBT) principles was developed. Patients in the PEG group will be involved in three sessions of psychoeducation. The PEG program is designed to cover the various aspects outlined by the IOM on quality cancer survivorship.
BEHAVIORALUsual Care
Usual Care
Sponsors
National University of Singapore
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
21 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with breast cancer were included if they met the following criteria: * 21 years or older * able to read and understand either English or Mandarin * diagnosis of Stages 1-3 breast cancer by a medical oncologist * completed adjuvant cytotoxic treatment
Exclusion criteria
* Diagnosed with severe psychiatric diagnosis such as severe cognitive disorders, mood disorders (psychiatric disorders requiring hospitalization) or serious personality disorders).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of anxiety, as measured using Beck Anxiety Inventory | Within one month after the program |
| Quality of life | Within one month after the program |
Secondary
| Measure | Time frame |
|---|---|
| Severity of cognitive dysfunction, as measured using FACT-Cog | Within one month after the program |
| Severity of symptom burden, as measured using Rotterdam Symptom Checklist | Within one month after the program |
Countries
Singapore
Outcome results
None listed